A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
114 locations incl. Birmingham
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 12, 2026
Clinical Research of Philadelphia, LLC
Clinical research site in Philadelphia, Pennsylvania · 9501 ROOSEVELT BLVD STE 208, PHILADELPHIA, PA 19114-1027 · (215) 676-6696 · Website
As of July 2026, 16 paid clinical trials are recruiting at Clinical Research of Philadelphia, LLC in Philadelphia, Pennsylvania. Active studies at this site cover conditions such as Migraine, Lichen Planopilaris and Lupus Erythematosus, Systemic. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Clinical Research of Philadelphia, LLC (16)
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for Lichen Planopilaris
47 locations incl. Birmingham
Sponsor: Priovant Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for Lupus Erythematosus, Systemic
34 locations incl. Beverly Hills
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 75
Code: NCT07438496·Phase 3·Recruiting·Listed Feb 2026
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
127 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
for Hidradenitis Suppurativa
78 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 12+
Code: NCT05889182·Phase 3·Recruiting·Listed Jun 2023
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for Atopic Dermatitis
66 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18 - 63
Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for High Risk Cardiovascular Disease
261 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
for Menstrual Migraine
32 locations incl. Phoenix
Sponsor: Pfizer
Sex: Female·Age: 18 - 45
Code: NCT06641466·Phase 3·Recruiting·Listed Oct 2024
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
for Dermatitis Atopic
43 locations incl. Birmingham
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT06241118·Phase 3·Recruiting·Listed Feb 2024
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for Transthyretin Amyloidosis With Cardiomyopathy
39 locations incl. La Jolla
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07052903·Phase 3·Recruiting·Listed Jul 2025
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for Generalized Myasthenia Gravis
32 locations incl. Birmingham
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT04202341·Recruiting·Listed Dec 2019
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
for Arthritis, Psoriatic
16 locations incl. Searcy
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07321873·Phase 2·Recruiting·Listed Jan 2026
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for Urinary Incontinence,Stress
20 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: Female·Age: 18+
Code: NCT07202884·Phase 3·Recruiting·Listed Oct 2025
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
for Transthyretin-Mediated Amyloidosis
12 locations incl. La Jolla
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: All ages
Code: NCT04561518·Recruiting·Listed Sep 2020
Lysosomal Acid Lipase (LAL) Deficiency Registry
for Lysosomal Acid Lipase Deficiency
20 locations incl. Phoenix
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT01633489·Recruiting·Listed Jul 2012
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
for Cutaneous Sarcoidosis
4 locations incl. San Francisco
Sponsor: Priovant Therapeutics, Inc.
Sex: All·Age: 18 - 75
Code: NCT06978725·Phase 2·Recruiting·Listed May 2025
More research sites in Philadelphia
- University of Pennsylvania (357 trials)
- Children's Hospital of Philadelphia (306 trials)
- Thomas Jefferson University Hospital (112 trials)
- Thomas Jefferson University (95 trials)
- Fox Chase Cancer Center (94 trials)
- Hospital of the University of Pennsylvania (87 trials)
- The Children's Hospital of Philadelphia (42 trials)
- Temple University (39 trials)
- Temple University Hospital (38 trials)
- University of Pennsylvania/Abramson Cancer Center (30 trials)
Explore more
Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials